Low-grade brain tumors known as IDH-mutant gliomas CNS WHO grade 2 are life-threatening in spite of their slow growth.

The molecular understanding of brain tumors has undergone a profound transformation in recent years. Advances in genomics, ...

Scientists have identified a promising target for treatment of a devastating autoimmune disease affecting the brain.

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the Sbarro Institute in Philadelphia, the National Cancer Institute – Pascale ...